Armistice Capital’s Zivo Bioscience, Inc. Common Stock ZIVO Stock Holding History

Armistice Capital’s Portfolio ZIVO Stock Details ZIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-133,645	Closed	-$1.04M	–	367
2023 Q3	$1.04M	Sell	133,645 -37,000	-22%	-$412K	0.02%	145
2023 Q2	$2.48M	Buy	+170,645	New	+$2.9M	0.04%	140

Other funds holding ZIVO

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.82B AUM 15.4% 1-Year Est. Return

Armistice Capital's ZIVO Position: Q4 2023 in Review

Armistice Capital sold out of Zivo Bioscience, Inc. Common Stock (ZIVO) in Q4 2023, closing a stake of 133,645 shares — an estimated $1.04M sold.

Armistice Capital first reported a position in ZIVO in Q2 2023 and held it in 2 quarters. The position peaked at $2.48M in Q2 2023. 2 funds tracked by Wall St. Rank hold ZIVO as of Q4 2023.

Armistice Capital reported no remaining Zivo Bioscience, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Armistice Capital sold 133,645 Zivo Bioscience, Inc. Common Stock shares in Q4 2023, an estimated $1.04M.
Armistice Capital first reported a position in Zivo Bioscience, Inc. Common Stock in Q2 2023 and held it in 2 quarters.
Armistice Capital's Zivo Bioscience, Inc. Common Stock position peaked at $2.48M in Q2 2023.
2 funds tracked by Wall St. Rank held Zivo Bioscience, Inc. Common Stock as of Q4 2023.

Based on Armistice Capital's 13F filing for Q4 2023, filed 13 Feb 2024.